Unafra (opiranserin) / Vivozon  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Unafra (opiranserin) / Vivozon
NCT03997838: Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

Hourglass Jan 2020 - Dec 2020 : Topline data from P3a trial in abdominal plastic surgery
Completed
3
307
US
VVZ-149 Injections, Opiranserin Injections, Placebo
Vivozon, Inc.
Pain, Postoperative
08/19
08/19
NCT04430088: Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

Unknown status
3
300
US
VVZ-149 Injections, Placebo
Vivozon, Inc.
Pain, Postoperative
12/20
01/21
NCT05764525: Phase 3 Efficacy and Safety of VVZ-149 Injections for Postoperative Pain Following Laparoscopic Colectomy

Completed
3
285
RoW
VVZ-149 Injections, Opiranserin Injections, Placebo
Vivozon Pharmaceutical Inc.
Pain, Postoperative, Acute Pain
11/22
11/22

Download Options